Life Sciences in China: the CEO’s Perspective | KPMG | CN

Life Sciences in China: the CEO’s Perspective

Life Sciences in China: the CEO’s Perspective

This report outlines KPMG viewpoints, as well as those of senior executives in China’s life sciences sector, on the prospects of the industry.

1000

Contact

Related content

 Life Sciences in China: the CEO’s Perspective

China’s life sciences industry has expanded at a faster rate than the economy as a whole. It remains one of the most buoyant sectors.

KPMG China interviewed a number of senior executives in producing Life Sciences: the CEO’s Perspective. This publication highlights key trends in the industry such as reforms to the drug tendering process and advances in data analytics and other technologies.

Connect with us